Literature DB >> 15104373

Influence of age, sex, and degree of liver fibrosis on the association between serum alanine aminotransferase levels and liver inflammation in patients with chronic hepatitis C.

Hidenori Toyoda1, Takashi Kumada, Seiki Kiriyama, Yasuhiro Sone, Makoto Tanikawa, Yasuhiro Hisanaga, Kazuhiko Hayashi, Takashi Honda, Teiji Kuzuya.   

Abstract

In 504 patients with chronic hepatitis C who underwent liver biopsy, the correlation between serum ALT levels and histologic liver inflammation was investigated, and the effects of age, sex, and degree of histologic liver fibrosis on this correlation were analyzed. Serum ALT levels were significantly higher in male than in female patients only when activity of hepatitis was mild. In contrast, ALT levels were significantly higher in younger (< or = 50 years old) than in older patients only when activity of liver inflammation was severe. Fibrosis was closely associated with activity of hepatitis and, also, serum ALT level. More importantly, a significant number of older patients and patients with severe hepatic fibrosis had severe hepatic inflammation even when their serum ALT level was not markedly elevated (< or = 70 IU/L). Age, sex, and degree of liver fibrosis independently influenced serum ALT levels in patients with chronic hepatitis C.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15104373     DOI: 10.1023/b:ddas.0000017454.46589.66

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  19 in total

Review 1.  Evaluation of abnormal liver-enzyme results in asymptomatic patients.

Authors:  D S Pratt; M M Kaplan
Journal:  N Engl J Med       Date:  2000-04-27       Impact factor: 91.245

2.  Transaminases in serum and liver correlated with liver cell necrosis in needle aspiration biopsies.

Authors:  S ZELMAN; C C WANG
Journal:  Am J Med Sci       Date:  1959-03       Impact factor: 2.378

3.  [Activity determination of enzymes of energy-producing metabolism in human serum and liver punctate in liver diseases; enzyme activity determination in human liver. III].

Authors:  E SCHMIDT; F W SCHMIDT; E WILDHIRT
Journal:  Klin Wochenschr       Date:  1958-03-15

4.  Factors associated with serum alanine transaminase activity in healthy subjects: consequences for the definition of normal values, for selection of blood donors, and for patients with chronic hepatitis C. MULTIVIRC Group.

Authors:  A Piton; T Poynard; F Imbert-Bismut; L Khalil; J Delattre; E Pelissier; N Sansonetti; P Opolon
Journal:  Hepatology       Date:  1998-05       Impact factor: 17.425

Review 5.  Treatment of patients with hepatitis C and normal serum aminotransferase levels.

Authors:  Bruce R Bacon
Journal:  Hepatology       Date:  2002-11       Impact factor: 17.425

6.  Relationship of aminotransferases to liver histological status in chronic hepatitis C.

Authors:  M M Haber; A B West; A D Haber; A Reuben
Journal:  Am J Gastroenterol       Date:  1995-08       Impact factor: 10.864

7.  The significance of baseline serum alanine aminotransferase on pretreatment disease characteristics and response to antiviral therapy in chronic hepatitis C.

Authors:  S C Gordon; J W Fang; A L Silverman; J G McHutchison; J K Albrecht
Journal:  Hepatology       Date:  2000-08       Impact factor: 17.425

8.  Evaluation of liver histology, ALT elevation, and HCV RNA titer in patients with chronic hepatitis C.

Authors:  S E McCormick; Z D Goodman; C L Maydonovitch; M H Sjogren
Journal:  Am J Gastroenterol       Date:  1996-08       Impact factor: 10.864

9.  Updated definitions of healthy ranges for serum alanine aminotransferase levels.

Authors:  Daniele Prati; Emanuela Taioli; Alberto Zanella; Emanuela Della Torre; Sonia Butelli; Emanuela Del Vecchio; Luciana Vianello; Francesco Zanuso; Fulvio Mozzi; Silvano Milani; Dario Conte; Massimo Colombo; Girolamo Sirchia
Journal:  Ann Intern Med       Date:  2002-07-02       Impact factor: 25.391

10.  Detection of hepatitis C virus RNA by a two-stage polymerase chain reaction with two pairs of primers deduced from the 5'-noncoding region.

Authors:  H Okamoto; S Okada; Y Sugiyama; T Tanaka; Y Sugai; Y Akahane; A Machida; S Mishiro; H Yoshizawa; Y Miyakawa
Journal:  Jpn J Exp Med       Date:  1990-08
View more
  2 in total

1.  Higher Serum Alanine Transaminase Levels in Male Urokinase-Type Plasminogen Activator-Transgenic Mice Are Associated With Improved Engraftment of Hepatocytes but not Liver Sinusoidal Endothelial Cells.

Authors:  Marina E Fomin; Ashley I Beyer; Jean Publicover; Kai Lu; Sonia Bakkour; Graham Simmons; Marcus O Muench
Journal:  Cell Med       Date:  2016-11-23

2.  Efficacy of MK615 for the treatment of patients with liver disorders.

Authors:  Atsushi Hokari; Tomohisa Ishikawa; Hisao Tajiri; Takahide Matsuda; Osamu Ishii; Nobuyuki Matsumoto; Chiaki Okuse; Hideaki Takahashi; Takeshi Kurihara; Ko-Ichi Kawahara; Ikuro Maruyama; Mikio Zeniya
Journal:  World J Gastroenterol       Date:  2012-08-21       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.